Skip Navigation


Human Reproduction Update Advance Access originally published online on March 8, 2007
Human Reproduction Update 2007 13(4):357-364; doi:10.1093/humupd/dmm005
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
13/4/357    most recent
dmm005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gelbaya, T.A.
Right arrow Articles by Nardo, L.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gelbaya, T.A.
Right arrow Articles by Nardo, L.G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis

T.A. Gelbaya1, M. Kyrgiou2, T.C. Li3, C. Stern4 and L.G. Nardo5,6

1 Department of Obstetrics and Gynaecology, Royal Bolton Hospital, Bolton, UK 2 Department of Obstetrics and Gynaecology, Hammersmith Hospital, Queen Charlotte's and Chelsea Hospital, London, UK 3 Department of Obstetrics and Gynaecology, Jessop Wing, Sheffield, UK 4 Royal Women's Hospital and Melbourne IVF Unit, Melbourne, Australia 5 Department of Reproductive Medicine, St Mary's Hospital and Division of Human Development, University of Manchester, UK

6 Correspondence address: Department of Reproductive Medicine, St Mary's Hospital, CMMC University Hospitals, Whitworth Park, Manchester M13 0JH, UK. Fax: +44 0161-224-0957; E-mail: luciano.nardo{at}cmmc.nhs.uk

Despite recent advances in ovarian stimulation regimens and laboratory techniques, the pregnancy rate of assisted reproduction remains relatively low. New methods that would potentially improve implantation rates are needed. One proposed strategy involves enhancement of blood flow at the implantation site with the use of low-dose aspirin. We conducted a systematic review and meta-analysis to investigate the effect of low-dose aspirin on likelihood of pregnancy in women undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI). An electronic search of the literature was conducted targeting reports published over the last 26 years. Only randomized controlled trials (RCTs) comparing aspirin with placebo or no treatment in IVF/ICSI women were included in the meta-analysis. A number of relevant outcomes including pregnancy and live birth (LB) rates were investigated. Pooled relative risk (RR) and 95% confidence interval (CI) were calculated using a random-effects model. Inter-study heterogeneity among the trials was assessed using the Cochran's Q test. Ten RCTs were identified from the literature search, six of which met the criteria for inclusion in the meta-analysis. Clinical pregnancy (CP) rate per embryo transfer (ET) was not found to be significantly different between patients who received low-dose aspirin and those who received placebo or no treatment (RR 1.09, 95% CI 0.92–1.29). None of the other outcomes, including CP per cycle, spontaneous abortion or ectopic pregnancy per CP and LB rate per cycle or ET was found to differ significantly between the compared groups. On the basis of up-to-date evidence, low-dose aspirin has no substantial positive effect on likelihood of pregnancy and, therefore, it should not be routinely recommended for women undergoing IVF/ICSI.

Key words: aspirin / IVF / implantation / endometrium / pregnancy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
K. Dirckx, P. Cabri, A. Merien, L. Galajdova, J. Gerris, M. Dhont, and P. De Sutter
Does low-dose aspirin improve pregnancy rate in IVF/ICSI? A randomized double-blind placebo controlled trial
Hum. Reprod., April 1, 2009; 24(4): 856 - 860.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Haapsamo, H. Martikainen, and J. Rasanen
Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF/ICSI: a randomized, placebo-controlled, double-blind study
Hum. Reprod., April 1, 2009; 24(4): 861 - 866.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
M. J. Lambers, V. Mijatovic,, and P. G.A. Hompes
Low dose aspirin and IVF: 'Is it time for a meta-analysis'? Continued: the consequences of the choices made
Hum. Reprod. Update, March 1, 2009; 15(2): 262 - 263.
[Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S. A. R. Doi
Low dose aspirin and IVF: 'Is it time for a meta-analysis' continued?
Hum. Reprod. Update, September 1, 2008; 14(5): 537 - 538.
[Full Text] [PDF]


Home page
ESHRE MonogrHome page
W. Ombelet, R. Campo, E. Bosmans, and M. Nijs
Intrauterine insemination (IUI) as a first-line treatment in developing countries and methodological aspects that might influence IUI success
ESHRE Monogr, July 1, 2008; 2008(1): 64 - 72.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
T. A. Gelbaya, M. Kyrgiou, and L. G. Nardo
Reply: 'Is it time for meta-analysis?'
Hum. Reprod. Update, May 1, 2008; 14(3): 289 - 291.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.